Yet, detailed examination of MTL subfield volumes and drivers of atrophy in amnestic EOAD is lacking.<h4>Methods</h4>BioFINDER-2 participants with memory impairment, abnormal amyloid-β status and tau-PET were included. This evidence concerns the gene MAPT and memory impairment.